BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11106352)

  • 1. Neurofibromatosis type 2.
    Evans DG; Sainio M; Baser ME
    J Med Genet; 2000 Dec; 37(12):897-904. PubMed ID: 11106352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofibromatosis type 2].
    Pérez-Grau M; Miró N; Prades J; Vergés J; Lareo S; Roca-Ribas F
    Acta Otorrinolaringol Esp; 2010; 61(4):306-11. PubMed ID: 20138250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
    Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
    Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
    Ruggieri M; Praticò AD; Evans DG
    Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 2 (NF2): a clinical and molecular review.
    Evans DG
    Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis type 2].
    Goutagny S; Bouccara D; Bozorg-Grayeli A; Sterkers O; Kalamarides M
    Rev Neurol (Paris); 2007 Sep; 163(8-9):765-77. PubMed ID: 17878803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 2.
    Evans DG
    Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 2 (NF2): diagnosis and management.
    Lloyd SK; Evans DG
    Handb Clin Neurol; 2013; 115():957-67. PubMed ID: 23931824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoblotting analysis of schwannomin/merlin in human schwannomas.
    Harwalkar JA; Lee JH; Hughes G; Kinney SE; Golubić M
    Am J Otol; 1998 Sep; 19(5):654-9. PubMed ID: 9752976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 2: a new mechanism of tumor suppression.
    Lutchman M; Rouleau GA
    Trends Neurosci; 1996 Sep; 19(9):373-7. PubMed ID: 8873351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM; Kaye AH
    J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 2.
    Evans GR; Lloyd SKW; Ramsden RT
    Adv Otorhinolaryngol; 2011; 70():91-98. PubMed ID: 21358190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis Type 2.
    Ardern-Holmes S; Fisher G; North K
    J Child Neurol; 2017 Jan; 32(1):9-22. PubMed ID: 27655473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2.
    Sperfeld AD; Hein C; Schröder JM; Ludolph AC; Hanemann CO
    Brain; 2002 May; 125(Pt 5):996-1004. PubMed ID: 11960890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis type 2.
    Asthagiri AR; Parry DM; Butman JA; Kim HJ; Tsilou ET; Zhuang Z; Lonser RR
    Lancet; 2009 Jun; 373(9679):1974-86. PubMed ID: 19476995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.